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Analysis of opo cis-regulatoryQ1 landscape uncovers
Vsx2 requirement in early eye morphogenesis
Ines Gago-Rodrigues1, Ana Ferna´ndez-Min˜a´n1, Joaquin Letelier1, Silvia Naranjo1, Juan J. Tena1,
Jose´ L. Go´mez-Skarmeta1 & Juan R. Martinez-Morales1
The self-organized morphogenesis of the vertebrate optic cup entails coupling the activation
of the retinal gene regulatory network to the constriction-driven infolding of the retinal
epithelium. Yet the genetic mechanisms underlying this coordination remain largely
unexplored. Through phylogenetic footprinting and transgenesis in zebrafish, here we
examine the cis-regulatory landscape of opo, an endocytosis regulator essential for eye
morphogenesis. Among the different conserved enhancers identified, we isolate a single
retina-specific element (H6_10137) and show that its activity depends on binding sites for the
retinal determinant Vsx2. Gain- and loss-of-function experiments and ChIP analyses reveal
that Vsx2 regulates opo expression through direct binding to this retinal enhancer.
Furthermore, we show that vsx2 knockdown impairs the primary optic cup folding. These data
support a model by which vsx2, operating through the effector gene opo, acts as a central
transcriptional node that coordinates neural retina patterning and optic cup invagination in
zebrafish.
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The organogenesis of the vertebrate eye is a complex processthat involves the precise integration of inductive signals,intrinsic genetic programs and morphogenetic movements.
As the general vertebrate body plan is established, the
main architecture of the eye is acquired in the developmental
window comprised between the specification of the eye field
at early gastrulation and the onset of neuronal differentiation
at pharyngula stage1,2. During this period, an initially
undifferentiated mass of precursor cells in the anterior neural
plate differentiates into the neural retina, the retinal pigmented
epithelium (RPE) and the optic stalk domains. Signalling
molecules emanating from adjacent tissues (for example,
SHH from the midline, activins from the extraocular
mesenchyme and fibroblast growth factors (FGFs) from the
presumptive lens) activate domain-specific transcriptional
regulators, which in turn restrict the precursors’ potentiality
and specify the features of the different eye subdivisions2–4.
The formation of defined boundaries between adjacent domains
often depends on reciprocal transcriptional repression. This
mechanism is exemplified by the mutual repression between
Pax2/Pax6, which helps defining the border between optic stalk
and optic cup5.
The neural retina domain is specified in the distal optic
vesicle under the influence of FGFs, derived either from the
lens ectoderm or the neuroepithelium itself6–9. In a number
of vertebrate models, ectopic activation of the FGF–MAPK
pathway seems to be sufficient to transdifferentiate the RPE
into retina. This transformation involves the general
downregulation of the RPE gene regulatory network,
particularly the repression of a key specifier, the bHLH TF
Mitf3,10,11.
The gene encoding for the homeodomain TF Vsx2, formerly
known as Chx10, is the earliest domain-specific marker expressed
in the presumptive neural retina12. Initial analysis of Vsx2 function
described that its mutation in mice (ocular retardation, orj)
resulted in microphthalmia, and revealed its essential role in
neuroepithelial proliferation and bipolar cells differentiation13.
Similar phenotypes were also observed in human Vsx2mutations14
and in vsx2-depleted embryos in zebrafish15,16. More recent studies
on early stages of eye development have shown that Vsx2 represses
Mitf and hence RPE identity, thus acting as a central component of
the gene regulatory network involved in the specification of the
neural retina domain17–20. Interestingly, the FGF-induced
reprogramming of the RPE lineage does not occur in null
mutant mice for Vsx2 (ref. 18), thus indicating that Vsx2 is an
essential downstream node in the MAPK–FGF pathway,
responsible for neural retina determination.
As tissue patterning takes place, eye precursors within their
different domains undergo a coordinated series of morphogenetic
movements that shape the primordium into a hemispheric optic
chamber21–23. Two major characteristic movements have been
described by anatomical observations and live-imaging recordings
in all vertebrate models. The first, known as evagination, results in
the formation of bilateral optic vesicles either by the lateral bulging
of coherent epithelial sheets, as reported in tetrapods24,25, or by the
rearrangement of individual cells, as described in teleost
models26,27. In a second series of coordinated movements (that
is, invagination), the neural retina and RPE domains fold to form a
bilayered cup that covers the lens vesicle, which simultaneously
invaginates from the surface ectoderm21,25,28. Although contractile
interepithelial filopodia have been shown to participate in the fine-
tuning mechanism that coordinates optic cup and lens
morphogenesis29, a number of studies indicate that both tissues
fold following cell intrinsic-independent mechanisms. Recent
data in mice have shown that the invagination of the lens
ectoderm is achieved through an apical constriction mechanism
driven by the RhoA-dependent activation of the actin regulator
Shroom3 (refs 30,31). In contrast, the inward folding of the
neural ectoderm has been described, both in mammals and
teleosts, as a tissue-autonomous mechanism depending on integrin
function28,32. Mutant analysis in medaka (Oryzias latipes) has
identified the vertebrate-specific transmembrane protein Opo,
encoded by the gene ojoplano (opo), as an essential component of
the molecular machinery involved in neural retina
morphogenesis28,33. Opo is a hypomorphic splicing mutation
that results in a premature stop codon in a fraction of the mature
transcripts, and thus in a reduction of wild-type protein levels. In
opo mutants, focal adhesion components are not efficiently
recruited to the basal surface of the retinal neuroepithelium and
the folding of the optic cup is severely impaired28. More recently,
biochemical analyses have shown that Opo controls the polarized
endocytosis of integrins through interference with the clathrin
adaptors Numb and Numbl (ref. 34).
It seems a logical assumption that tissue patterning and
morphogenetic movements are coordinated phenomena. Yet little
is known about the molecular link between transcriptional
specifiers and morphogenetic effectors during eye develop-
ment35,36. Here we perform a comprehensive analysis of the
genomic landscape of the morphogenetic regulator opo. Through a
combination of phylogenetic footprinting, analysis of epigenetic
marks and transgenesis assays in zebrafish, we explore the
regulatory input onto the opo promoter. Among the nine tissue-
specific enhancers identified, H6_10137 exclusively drives the
expression in the neural retina domain. We show that regulatory
activity by H6_10137 depends on evolutionarily conserved Vsx2-
binding sites, and demonstrate the physical interaction between
Vsx2 and the eye enhancer in vivo. Furthermore, we show that
vsx2 regulates opo expression both in gain- and loss-of-function
experiments. Finally, vsx2 morpholino knockdown in zebrafish
results in a range of eye malformations, including microphthalmia
and optic cup folding defects resembling the ocular phenotype of
opomutants. In addition to its well-established role as a specifier of
the retinal domain, our data indicate a role for Vsx2 in optic cup
morphogenesis. According to our model, vsx2 would act as a
genetic hub that coordinates neural retina patterning and
morphogenesis in the developing zebrafish eye.
Results
Identification of CNEs in the opo locus. The developmental
gene opo plays an essential role during the morphogenesis of a
number of tissues including the eye, brain, heart, fins and neural
crest derivatives28. Opo is present as a single copy in the genome
of all vertebrates studied and, together with its neighbor genes
tfap2a and slc35b3, forms a relatively large syntenic block
(B2Mb in mammalian genomes). Its human orthologue, also
known as orofacial cleft candidate 1 (ofcc1) is located at the distal
region of chromosome 6p (6p23.4). This region has been
associated to hereditary congenital diseases such as orofacial
clefting37, schizophrenia38 and Tourette syndrome39.
To gain insight into the opo regulatory logic, we first used a
phylogenetic footprinting approach to detect potential cis-
regulatory elements conserved among vertebrate genomes. Using
Vista alignment tools, we identified and cloned a collection of 23
highly conserved (Z70% identity from mammals to teleosts)
non-coding elements (CNEs) distributed throughout the human
locus (Fig. 1a; Supplementary Table 1). Interestingly, although the
genomic region including opo covers only 2% of the chromosome
6, it contains 23% of the CNEs within this chromosome (Fig. 1b).
This suggests that opo has a complex regulatory input, as
previously reported for other developmental genes40. For each
CNE, we then examined the co-occurrence of the predictive
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enhancer epigenetic marks H3K4me1 and H3K27ac, as
determined in previous chromatin immunoprecipitation
(ChIP)-Seq studies in human cell lines41,42 and, for their
homologous regions, in zebrafish embryos43. These analyses
revealed that a large majority of the identified CNEs (21 out of
23) overlap with regions labelled with at least one epigenetic
mark, either in human cell lines, zebrafish embryos or both
(Supplementary Table 2), suggesting that these conserved regions
may act as enhancers. As a reference, four non-conserved
elements (named here H6_09628, H6_09941, H6_10309 and
H6_10455) tagged with H3K4me1 and H3K27ac marks in human
cell lines (Fig. 1a) were also cloned and included in further
analyses.
The distribution of opo transcripts during development has
been described both in mouse and medaka tissues28,33, but not in
zebrafish, the model system used for functional analyses in this
study. To extend our observations to zebrafish embryos, we
performed fluorescent in situ hybridization analyses at stages 20,
24 and 48 h.p.f. (Fig. 1c–e). In agreement with previous data in
other vertebrates, opo mRNA localized mainly at the basal side of
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Figure 1 | Opo landscape. (a) Representation of the opo landscape in 6p24.3 of the human genome (NCBI36/hg18), showing opo/orofacial clefting candidate
1 (opo/ofcc1) and TF ap-2 alpha (tfap2a). The sequence conservation among six vertebrate species (grey) is represented above. The sum of H3K4me1
and H3K27ac marks for human cell lines are shown in light blue and purple, respectively. Both conserved CNEs and non-conserved reference
elements (RNEs) are indicated in dark blue bars. The CNE marked in grey was not screened for enhancer activity. Orofacial clefting break-point regions
(OFC), Tourett syndrome mutation (TS: chr6:10041064) and Schizophrenia-linked (Schiz) markers are also represented. (b) The opo locus represents 2%
of the size (Mb) of the chromosome six and contains 23% of all the non-coding highly conserved elements in this chromosome. Non-coding highly
conserved bp in the locus versus non-coding highly conserved bp in the rest of the chromosome are represented. (c–e) Whole-mount FISH show the
localization of opo transcripts in basal retina (br), cranial neural crest (cnc), ear (e), lens (l), central nervous system (cns), retina ciliar marginal zone
(rcmz), pharyngeal arches (pa) and in the epidermal ridge of the pectoral fins (pf). (f–h) GFP expression of the stable transgenic line Tg(opo5kbup:GFP) in
retina (r), cranial neural crest (cnc), pharyngeal arches (ba) and retina ciliary marginal zone (rcmz).
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the retinal epithelium, lens, brain and neural crest precursors at
early stages (20–24 h.p.f.; Fig. 1c,d; Supplementary Fig. 1). Later
on, at 48 h.p.f., opo expression appeared more prominent at the
retinal ciliary marginal zone, pharyngeal arches, inner ear and
pectoral fins (Fig. 1e; Supplementary Fig. 1). Using these
observations as a reference, we then examined whether the
genomic region found immediately upstream of the opo
transcription start site contained enough regulatory information
to recapitulate the entire expression pattern of the gene. To
answer this question, we took advantage of the compact genome
size in medaka (800Mb), as well as the precise annotation of the
opo transcription start site in this species. A 5.6-kb fragment,
containing both the medaka promoter of the gene and some
proximal elements (that is, including the homologous regions of
the human CNEs here termed H6_10126 and H6_10137), was
cloned into a reporter (enhanced green fluorescent protein
(eGFP)) vector and screened in transgenic assays in zebrafish.
The examination of the stable lines (n¼ 3) generated by the
injection of the Tg(opo5Kbup:GFP) construct showed that the opo
proximal region drives the reporter expression to the developing
eye and pharyngeal arches (Fig. 1f–h). Although these tissues
comprise a significant part of the whole opo expression pattern,
the proximal 5.6-kb element failed to drive the reporter into
several domains (for example, the early migratory cephalic neural
crest, lens, brain and pectoral fins). This observation suggests that
additional cis-regulatory elements cooperate to control opo
transcription.
Functional identification of opo enhancers. To investigate
whether some of the identified CNEs behave as active enhancers,
we tested them individually by transgenesis analysis in zebrafish. In
these experiments, we used the zebrafish enhancer detector system
(ZED), a Tol2-mediated transgenesis shuttle that includes a
minimal promoter linked to GFP and a cardiac-actin:RFP (red
fluorescent protein) cassette as an internal control for transgen-
esis44. The progeny (F1) of the putative transgenic fish (founders)
was screened for the reporter expression between 24 and 72h.p.f.
(Supplementary Table 3). We observed that 12 out of the 23 CNEs
tested (52%) were able to activate the GFP expression. In contrast,
none of the four non-conserved elements marked for H3K4me1
and H3K27ac behaved as an enhancer in the developmental
window considered in our screen. Among the 12 positives CNEs,
we found an irreproducible GFP pattern between founders in three
cases, suggesting that these elements either do not act as specific
enhancers or require additional regulatory information to be
active. The remaining nine consistently directed distinct
tissue-specific expression patterns in several independent
founders (three or more), and were considered functional
enhancers (Supplementary Table 3). Several of these elements
directed reporter expression in the brain or craniofacial derivatives
(Fig. 2a–i), whereas other territories such as the lens or the fins
were the targets of a single enhancer (Fig. 2e,f). Significantly, we
identified only a single enhancer, H6_10137, driving the reporter
expression in the neural retina domain (Fig. 2g). A detailed
description of the expression domains controlled by each
individual enhancer is shown in Table 1 and summarized in
Fig. 2j. Most of the enhancers were located either 50 or 30 of the opo
transcriptional unit, and a single intronic enhancer, H6_09949, was
identified (Fig. 2k). Interestingly, four of the identified elements,
H6_09516, H6_09601, H6_09949 and H6_10137, belong to the
collection of 557 ancient pan-vertebrate aCNEs conserved both in
cartilaginous and bony vertebrate lineages45.
Analysis of potential regulatoryQ2 inputs on the H6_10137
enhancer. Taking into account the key role of opo during eye
development, we focused our attention on the eye-specific
enhancer H6_10137. To analyse its potential regulatory inputs, we
scanned for conserved TF-binding sites using the alignment tool
MultiTF at ECR browser46. The resulting list of putative
regulators (Supplementary Table 4) was further filtered to
examine their reported developmental expression patterns in
The Zebrafish Model Organism Database47. This approach
revealed a number of TFs expressed in the retinal tissue, such
as vsx2, crx, brca or pbx. Among them, the homeobox TF vsx2
shows an early and specific expression in the neural retina but not
in the RPE12,16, thus resembling most the spatiotemporal
activation of H6_10137 (Fig. 3a,a0). Manual ClustalX alignment
of the enhancer region for several vertebrate species confirmed
the conservation of the consensus binding site for vsx2 (ref. 14)
detected by multiTF (BS1:142–151 bp), and identified a second
conserved site (BS2: 678–687 bp) not initially detected using the
default parameters of the algorithm (Fig. 3b,c).
The presence of these conserved binding sites suggests a possible
interaction between the TF Vsx2 and the opo H6_10137 enhancer,
which is also consistent with both being expressed specifically at
the neural retina domain. To investigate whether the identified
Vsx2 BS1 and BS2-binding sites are required for the activity of the
H6_10137 enhancer, both binding sites were mutated (Fig. 3d).
The regulatory potential of the mutated enhancer mutH6_10137
(that is, its capacity to drive GFP expression into retina
progenitors) was then compared with that of H6_10137 in
transient transgenic assays (F0) in zebrafish. As positive transgen-
esis control, RFP expression controlled by the cardiac-actin:RFP
cassette was examined in the somites and heart, and thus the
presence of GFP-positive clones in the retina was scored only in
RFP-positive embryos (B20% of the injected embryos). While
42% of potential founders (that is, RFP-positive embryos) injected
with the H6_10137 construct showed typically elongated neuro-
blasts expressing GFP in the retina at 24 h.p.f., embryos injected
with the mutated construct mutH6_10137 did not show any GFP-
positive cells in this tissue (Fig. 3e–g). Therefore, the mutation of
Vsx2 consensus binding sites in the opo eye enhancer abolishes its
activity in neural retina precursors, suggesting that Vsx2 may act
through this sequence as a direct regulator.
Vsx2 regulates opo expression through direct Q3binding to
the H6_10137 enhancer. We reasoned that if the activity of
the H6_10137 element in the retina depends on Vsx2 binding, then
the loss of vsx2 function should affect the enhancer’s function and
hence the expression levels of opo. To address this point, we
designed morpholino oligonucleotides aimed to knockdown vsx2
expression in zebrafish. Two splicing morpholino oligonucleotides
were designed—I1E2MO and E2I2MO—affecting the splicing of
introns 1 and 2, respectively (Fig. 4a), and injected into zebrafish
embryos at the one-cell stage. Both morpholinos efficiently
interfered with splicing at the targeted intron-exon boundaries and
significantly reduced the levels of wild-type transcripts, as assessed
by quantitative reverse transcription-PCR (RT–qPCR) amplifica-
tion from morphant embryos’ complementary DNA (cDNA;
Fig. 4b,c). Sequencing of the aberrant transcripts confirmed the
intron retention events (that is, of intron 1 and 2, respectively, for
I1E2MO and E2I2MO) and consequently, the splicing disruption
of vsx2 mRNA in the morphants.
We then evaluated the effect of vsx2 knockdown on H6_10137
activity by injecting these morpholinos into one-cell-stage
transgenic embryos from the stable line Tg(H6_10137:eGFP).
Injection of both morpholinos resulted in conspicuous morpho-
logical eye defects, which will be discussed in the next section, and
caused a dramatic decrease of the levels of GFP signal in the
transgenic embryos at 24 h.p.f. (Fig. 4d–f). GFP signal could only
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be detected in 20–30% of the injected embryos (Fig. 4g). These
results indicate that a reduction of functional vsx2 in the neural
retina negatively impinges on the regulatory capability of
H6_10137, suggesting that vsx2 acts as a positive regulator of
the opo gene. To test this possibility, we examined both in vsx2
gain- and loss-of-function conditions the expression of opo by
RT–qPCR. The injection of I1E2MO and E2I2MO morpholinos
in zebrafish embryos, both separately or in combination, strongly
reduced opo levels in a dose-dependent manner, as determined by
RT–qPCRs (Fig. 5a,b) in 24-h.p.f. samples. This reduction became
even more evident when only the heads of knockdown embryos
were used as source material for the RT–qPCRs (Fig. 5b).
Conversely, the injection of zebrafish vsx2 RNA (100 and
300 ng ml" 1) into one-cell embryos resulted in a dose-dependent
enhancement of opo expression (Fig. 5c). Taken together, these
results show that vsx2 is a positive regulator of opo. ChIP followed
by quantitative PCRs (ChIP–qPCR) assays confirmed that this
regulation is exerted through direct binding of Vsx2 to the
H6_10137 enhancer. Indeed, RNA injection of a functional
tagged GFP_Zvsx2 fusion (Fig. 5d) followed by pull down using
anti-GFP antibodies, enabled determining a significant enrich-
ment in the ChIP sample of the endogenous zebrafish enhancer
(that is, the homologous region to the human H6_10137
fragment) when compared with the housekeeping gene ef1a,
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used as a negative control (Fig. 5e). This enrichment in the ChIP
sample was even higher than the observed for a fragment of the
vsx1_promoter, previously identified as a Vsx2 direct target48
(Fig. 5e). Therefore, these results indicate that the H6_10137
enhancer is a direct target of the TF Vsx2.
Vsx2 knockdown impairs optic cup folding. To further corro-
borate the role of vsx2 in eye morphogenesis, the morpholinos
I1E2MO and I2E2MO were injected in a transgenic
Tg(vsx2.2:GFPcaax) background. In this line, the membranes of
the neural retina precursors are specifically labelled facilitating
morphological observations. The analysis of the resulting mor-
phants revealed a similar range of ocular malformations for each
morpholino (Supplementary Table 5). A reduction of the eye size
(microphthalmia) and optic cup folding defects were observed in
66 and 57% of the I1E2MO and E2I2MO morphants, respectively
(Fig. 6a–c, a0–c0). In addition, most severely affected embryos
(12 and 15% of the I1E2MO and E2I2MO morphants, respec-
tively) displayed anophthalmia (Fig. 6d,d0). These defects were
specific since the co-injection of vsx2 RNA and morpholino
E2I2MO increased the percentage of embryos phenotypically
classified as wild type (73 versus 28% in E2I2MO-injected
embryos; Fig. 6e). In agreement with our observations (Fig. 6F
and Supplementary Table 6), microphthalmia has already been
described in vsx2 loss-of-function models in both mouse and
zebrafish13,16. Moreover, at optic cup stages, morphant retinas
showed reduced cell number without exhibiting increased cell
death (that is, pyknotic nuclei) or significant variation of the
mitotic index (Supplementary Fig. 2). These observations suggest
an extended M/G1 phase in the morphant retinas, as previously
demonstrated in Vsx2-mutant mice49.
Besides size reduction, we also observed that morphant retinas
remained ventrally opened at 24h.p.f., when the folding of the
optic cup is already completed in control embryos (Fig. 7a–f). To
analyse this phenomenon quantitatively, aperture angles were
measured at 24 h.p.f. in more than 100 embryos per morpholino.
This analysis revealed that around 70% of vsx2-knockdown
embryos displayed ventral clefts ranging from 21! to 120!, whereas
the range ventral opening in control embryos was between 0! and
20! (Fig. 7g; Supplementary Table 7). Interestingly, although
reduced retinal size and folding defects coexist frequently in the
morphant retinas, no significant correlation between these two
parameters was observed (Fig. 6g and Supplementary Table 8).
Taken together, these results point to an essential role for vsx2
during the folding of the optic cup in zebrafish.
To further investigate the epistatic relationship between vsx2
and opo, we took advantage of the hypomorphic condition of the
opo mutation in medaka (that is, 20% of the wild-type protein is
still synthetized)28. We tested whether vsx2 overexpression could
rescue opo ocular phenotype by injecting zebrafish vsx2 RNA into
one-cell-stage medaka embryos derived from opo heterozygous
crosses. Similar to our results in zebrafish, the injection of vsx2
RNA in medaka embryos (200 ngml" 1) also resulted in an
enhancement of opo expression (Supplementary Fig. 3).
Moreover, the predicted rescue was observed as a significant
reduction in the percentage of injected embryos showing an
ocular malformation phenotype (Fig. 7h–j). On injection of vsx2
RNA, the percentage of embryos displaying the characteristic
large ventral opening was reduced from an approximately
Mendelian proportion, 23.9±3.7%, as expected from a carriers’
cross, to 15,4±4.8% (Fig. 7k and Supplementary Table 9). This
result confirms the role of vsx2 as an upstream regulator of opo
function during optic cup folding.
Discussion
In this work, we have provided a comprehensive study of the
regulatory landscape harbouring the morphogenetic gene opo.
Within the large syntenic block that comprises slc35b3, opo and
tfap2a (B2Mb in humans), we have analysed a smaller domain
(1.5Mb in human genomes) that includes both opo and tfap2a.
This genomic area is flanked by CTCF-binding sites50 and contains
the enhancers identified in our analysis. The fact that opo and
tfap2a are not separated by CTCF-binding sites and that they are
both contained within the same topologically associating domain51
open the possibility that common cis-regulatory elements may co-
regulate these two genes. Indeed, opo and tfap2a may constitute a
small synexpression cluster in the genome, given their common
expression in neural crest derivatives and their role in craniofacial
development28,52. Here we have used a combination of
phylogenetic footprinting and predictive epigenetic marks to
identify candidate cis-regulatory regions (that is, CNEs and
active enhancers, respectively), which were then functionally
tested in transgenesis assays in zebrafish. Although this is a
systematic approach, it is reasonable to consider that the collection
of enhancers identified here represents an underestimate of the
actual number of regulatory regions in the locus. Some of the
CNEs that were unable to activate GFP expression in a
reproducible pattern in our assays may either require context-
dependent regulatory information or are simply active outside the
developmental window considered in this study. In fact, although
the tissue domains targeted by the identified enhancers recapitulate
most of the opo expression pattern, there are a few opo positive
tissues, such as the pronephros and the heart, for which no active
enhancers were identified.
The definition of chromatin architecture and cis-regulatory
regions within the opo locus is not only relevant to understand the
Table 1 | Expression domains of the enhancers identified in the opo locus.
opo locus enhancers GFP expression at early stages
(16–36h.p.f.)
GFP expression at later stages
(36–72h.p.f.)
Regulatory features
H6_09040 CNS (more intense at MHB) Weak expression in the ear 50 from opo; H3K4me1
H6_09516 Forebrain and pharyngeal arches Forebrain, pharyngeal arches, ears and jaw 50 from opo; H3K4me1
H6_09563 CNS and pituitary gland Forebrain; hindbrain, MHB, pituitary gland and
olfactory bulbs
50 from opo; H3K4me1, H3K4ac27
H6_09601 Forebrain Forebrain 50 from opo; H3K4me1, H3K4ac27
H6_09617 Forebrain, midbrain and CNC Forebrain, midbrain, lens and hyoid arch 50 from opo; H3K4me1, H3K4ac27
H6_09949 Forebrain, CNC and pectoral fins primordium Forebrain and pectoral fins opo intron; H3K4me1, H3K4ac27
H6_10137 Neural retina Dorsal neural retina 30 from opo; H3K4me1, H3K4ac27
H6_10377 Dorsal root ganglia and ears Dorsal root ganglia and ears 30 from opo; H3K4me1, H3K4ac27
H6_10431 Forebrain, pharyngeal arches and ears Forebrain, pharyngeal arches, ears and heart 30 from opo; H3K4me1, H3K4ac27
CNC, cephalic neural crest; CNS, central nervous system, GFP, green fluorescent protein; MHB, midbrain–hindbrain boundary.
Description of the GFP expression patterns associated to the CNEs with enhancer activity during early (16–36 h.p.f.) and late (36–72 h.p.f.) zebrafish development.
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transcriptional regulation of this developmental gene, but may also
be important in the context of human hereditary diseases.
Sequence variants linked to human diseases are frequently
associated to cis-regulatory regions53. In fact, among the three
translocation break points described within the locus in orofacial
cleft patients37, the 30 distal translocation t(6;9)(p24;q22.3) involves
a non-coding region that includes several of the conserved
enhancers identified in this study. Particularly relevant are the
enhancers H6_09516 and H6_09617, which drive the reporter
expression in facial derivatives, and hence are candidate regions to
be examined further in hereditary orofacial clefting.
The H6_10137 region is the only eye-specific enhancer
identified in our transgenesis screen of human CNEs in zebrafish.
The fact that opo is the only gene expressed early in the retina in
the genomic neighbourhood indicates that H6_10137 is an opo
enhancer. An equivalent region driving the expression to the
developing eye is present in the medaka 5.6-kb proximal element,
thus suggesting that the enhancer is not only conserved at
sequence level but also functionally in vertebrates. This is in line
with what has been observed for a majority of the CNEs
comparatively tested in vertebrate species54. Here we have
identified conserved binding sites for TF Vsx2 in the H6_10137
region, and showed that they are required to direct its regulatory
activity to the neural retina domain. Vsx2 has been characterized
both as a repressor and a context-specific activator20,55,56. In
agreement with its role as a transcriptional activator, our results
show that Vsx2 acts as a positive regulator of opo expression
in vivo. ChIP–qPCR and morpholino studies demonstrate that
Vsx2 can physically bind the H6_10137 enhancer and regulate its
activity. Interestingly, the injection of vsx2 RNA into one-cell-
stage transgenic embryos from the stable line Tg(H6_10137:eGFP)
did not result in the ectopic expression of the reporter beyond the
neural retina domain (not shown). This indicates that Vsx2 input
is necessary for the activity of the enhancer, but not sufficient to
confer tissue specificity to this genomic element. Thus, additional
regulatory inputs may act synergistically with Vsx2 to direct the
expression of the enhancer H6_10137 to the neural retina. This
could happen either through other regulatory regions of the
enhancer or via the conserved Vsx2-binding sites. In fact, Vsx2
sites overlap partially with the preferred binding sites of closely
related homeodomain proteins from the paired-like class57.
Therefore, the possibility that other retinal homeodomain
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proteins different from Vsx2 may regulate the enhancer through
these conserved sites cannot be ruled out. This is particularly the
case for the homeobox protein Rx, which is also a well-known
retinal determinant58.
Different roles have been proposed for Vsx2 during eye
development in vertebrates. This TF was initially identified in
mutant mice and human patients as an important regulator of
retinal precursors’ proliferation and lineage specification13,14.
Later studies in mice found that Vsx2 played an essential role in
the specification of the neural retina domain, mainly by
repressing Mitf family members Mitf and Tfec, and hence
preventing the activation of the RPE genetic programme17,18,20.
A number of knockdown studies in zebrafish have shown that the
reported role for Vsx2 in mammals is, at least, partially conserved
in teleosts. Thus, small eye phenotypes, abnormal bipolar cell
specification and Mitf upregulation have been described in
vsx2-knockdown embryos in zebrafish15,16,48. Interestingly, one
of these reports15 described abnormally shaped eyes displaying a
flattened morphology at early stages in zebrafish (24 h.p.f.). This
observation is in agreement with our results showing that vsx2 is
required during optic cup morphogenesis in zebrafish. The fact
that reduced retinal size and folding defects coexist in vsx2
morphant retinas poses the question as to whether the
morphological defects we observed on knockdown of vsx2 in
zebrafish are due to a proliferation deficiency. In the light of
current evidence, this seems an unlikely possibility. Although cell
proliferation was initially hypothesized as a cellular mechanism
operating during optic cup morphogenesis59, more recent reports
using DNA synthesis inhibitors have shown that proliferation is
largely dispensable for the morphogenesis of the nervous system
in Xenopus60 and of the optic cup in zebrafish21. In fact, optic cup
invaginates between 16 and 20 h.p.f. in zebrafish, a 4-h period in
which only a modest increase in cell number takes place21.
Moreover, here we show no significant correlation between
retinal size and optic cup folding defects on knockdown of vsx2 in
zebrafish (Fig. 6g), thus suggesting that vsx2 operates through
different genetic pathways to control retinal morphology and size.
In contrast to our observations, no optic cup morphogenetic
defects have been reported in Vsx2-mutant mice (orJ), despite the
range of variability described for this classical mutation13,61. A
couple of alternative explanations may account for this
discrepancy. First, Vsx2 may have a variable regulatory weight
on the optic cup morphogenetic programme in different vertebrate
groups. The fact that Vsx2 sites overlap with the binding sites of
closely related homeodomain proteins opens up the possibility that
several retinal determination genes cooperate with Vsx2 during
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optic cup morphogenesis, either through the opo H6_10137
enhancer or by regulating other unidentified morphogenetic genes.
These differential regulatory properties may even vary within
vertebrates, as optic cup malformations (that is, coloboma) have
been reported in families affected with non-syndromic
microphthalmia14,62. In fact, examples of differential input into
gene regulatory networks have been already described during optic
vesicle patterning in vertebrates. A prominent example is
Mitf, which seems to have a smaller regulatory influence in the
RPE specification network in zebrafish than in amniotes63.
Alternatively, as opo/Ofcc1 is a fast-evolving gene, its
developmental function may not be conserved in vertebrates. A
previous report isolated Opo/Ofcc1 in mouse, described the
existence of two different isoforms (A and B, 926 and 786 amino
acids, respectively), and characterized the expression of the gene
during development33. In an attempt to investigate the role of Opo
in mouse, a knockout mouse line deleting exons 3 and 4 of the
gene was generated64. However, this approach left the entire
coding sequence of the shorter isoform B intact, and the knockout
animals only displayed a very mild phenotype with asymptomatic
hyper-g-glutamyl-transpeptidasemia. A more comprehensive
strategy targeting both isoforms will be required to evaluate to
which extent the function of this gene is conserved among
vertebrates.
In conclusion, the systematic analysis presented here of the
regulatory input on the opo promoter has identified several
conserved tissue-specific enhancers, including the retinal-specific
element H6_10137. Our results indicate that vsx2, acting directly
via the H6_10137 enhancer, is an upstream positive regulator of
opo. Furthermore, we show an early requirement for vsx2 during
optic cup morphogenesis in zebrafish. We propose a model in
which Vsx2 acts as a direct transcriptional link between the
patterning of the optic vesicle and the morphogenetic effectors
mediating the constriction mechanism required for optic cup
folding (Fig. 8). This is a relevant link to understand how tissue
identity and epithelial morphogenesis are coordinated during the
formation of the vertebrate eye.
Methods
Identification cloning and transgenesis analysis of CNEs. A total of 24
conserved CNEs were selected within the opo locus using VISTA Browser65 and
taking as a reference the human genome (NCBI36/hg18) and the default
parameters (Z100 bp and Z70% identity). The presence of predictive epigenetic
marks for enhancer activity66 that overlap opo-associated CNEs was evaluated
using available data from human cell lines41,42 and zebrafish embryos43. As a
reference, four non-conserved elements marked with H3K4me1 and H3K27ac
signals in human cell lines were also tested in our enhancer screening. Twenty-
three CNEs were amplified from human genome (Supplementary Table 1) and
cloned into PCR8/GW/TOPO vector. Individual CNEs were then transferred to the
ZED vector44 using Gateway technology (Invitrogen). The CNE H6_09084 (chr6:
9084162-9086414) could not be cloned, despite multiple attempts. Zebrafish
embryos were microinjected at one-cell stage with 3–5 nl of a solution containing
25 nM of each CNE construct and 25 ng ml" 1 of Tol2 RNA. A minimum of 300
embryos per CNE was injected. Putative transgenic embryos, as determined by the
expression of the internal control of transgenesis (cardiac-actin:RFP), were
screened for tissue-specific enhancer activity.
Fluorescent RNA in situ hybridizations. Fluorescence in situ hybridization
experiments were preformed as previously described34. We used the following
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primers: 50-AAGTTGCAGCAGAAGGCTGTGGAG-30 and 50-ATTTTGCGGAAT
TGGTTGAG-30, a fragment of the opo gene was PCR amplified from zebrafish
cDNA (SuperScript VILO cDNA Synthesis Kit; Invitrogen). The PCR products
were cloned into pCR 2.1 TOPO TA cloning vector (Invitrogen), linearized with
Xba1 and transcribed with SP6 for riboprobe synthesis. The resulting probe was
used at a final concentration of 1.5 ng ml" 1.
Cloning of the medaka opo promoter region. A 5.6-kb region upstream of the
medaka opo start site28 was amplified from medaka genomic DNA by PCR using
the primers: 50-GTCAGCTATCACCGCAGTCGTCA-30 and 50-CCTCACTT
CCTTGTGCCGACATG-3. The PCR product was cloned into a PCR8/GW/TOPO
vector, transferred to the ZED vector and screened for tissue-specific enhancer
activity using zebrafish transgenic assays.
In silico prediction of TFfactor-binding sites. To scan for conserved TF DNA-
binding sites within the H6_10137 sequence, we used Mulan alignments and
multiTF search tools, available at the ECR browser (http://ecrbrowser.dcode.org/
)67. The expression pattern of the transcriptional regulators potentially binding the
identified motifs was analysed in the ZFIN database (http://zfin.org/)47. ClustalX
2.0 (ref. 68) was used for multispecies alignments.
Site-directed mutagenesis. Vsx2 DNA-binding sites were mutated in the
H6_10137-ZED construct by PCR, using QuikChange Multisite-Directed
Mutagenesis Kit (Agilent technologies). The following mutagenic primers were
used for PCR: 50-CTATTTTACATTTTCTTAATcgcCAAATCTTAATCTTGAC
TTTAATG-30 and 50-CATTATTAGCGGTCTctgCTTGAAGTTATATCAATG
TTAGT-30 . Mutagenized vectors were confirmed by sequencing. Both the muta-
genic-H6_10137 (mutH6_10137) and the H6_10137 enhancer constructs were
then injected in wild-type zebrafish, as described in the first paragraph of the
Methods section. The GFP and RFP activity of the injected vectors was assessed in
F0 at 24 and 48 h.p.f., respectively.
Morpholino injections. Two splicing morpholinos directed against zebrafish vsx2
were obtained from Gene Tools: I1E2MO: 50-TCATCTGAATCTGTAACATG
GAGGA-30 and E2I2MO: 50-TTTTCTTTAAGCCCACCTGTGTCGT-30 . Both
morpholinos were separately injected (8.5–13 ng per embryo) at one-cell stage in
wild-type embryos and in the transgenic lines: Tg(H6_10137:eGFP) and
Tg(vsx2.2::GFP:caax). When co-injected, the concentration range used was 6–10 ng
for each vsx2MO. To prevent potential apoptotic effects, a p53 morpholino
(p53MO: 50-GCGCCATTGCTTTGCAAGAATTG-30), was co-injected with
vsx2MOs at a concentration of 4–6 ng per embryo. Control embryos were injected
in parallel with water and p53MO alone. To assess morpholino efficiency, cDNA
samples were obtained from control and injected embryos at 24 h.p.f. cDNA
samples were then amplified with the following diagnosis primers: I1E2MOfw:
50-AGCACACTGGACTCCTTCCCCG-30 ; E2I2fw 50-GGGATTAATTGGGCCTG
GAGGTAT-30; I1E2MOrv and E2I2rv: 50-AGACTCGGGCAGAGGGATAG
AGTGA-30. PCR products were examined by electrophoresis and sequenced to
confirm aberrant splicing events induced by the morpholino. Eye phenotype in
morphants was examined at 24 h.p.f. using a fluorescent stereoscope (SZX16–
DP71, Olympus). GFP levels, ventral opening angles, retina length and forebrain
height were quantified using ImageJ1.45q (Wayne Rasband, National Institute of
Health, USA).
RT–qPCRs. qPCR reactions were performed using SsoFast Evagreen Supermix
(Bio-Rad) according to the manufacturer’s instructions in a CFX96 real-time
C1000 thermal cycler (Bio-Rad). Quantification of opo expression levels in
zebrafish was done using a forward primer placed on the second exon: 50-CGGT
CTTCGCTGTAGATGC-30 and a reverse primer placed on the third exon: 50-GAC
GGCGTAGAGGAATAATG-30 . The results were normalized with ef1a, amplified
with the following primers 50-CTTCTCAGGCTGACTGTGC-30 and 50-CCGC
TAGCATTACCCTCC-30. In medaka embryos, opo levels were quantified using the
following primers: 50-GGGGGACAATCGTTCATTAGA-30 and 50TCAGAAA
TTCAGCCGACTTGG-30 . b-actin and ef1a, used as internal controls in these
experiments, were amplified using primers for b-actin 50-CAACAGGGAGAAGA
TGACC-30 and 50-CCAGAGTCCATGACGATACCA and ef1a 50-AAACCCAGA
AACACCGAAACA and 50-CCTCCGCACTTGTAGATCAG.
RNA injections. Full-length zebrafish vsx2 was amplified from cDNA using the
primers 50-GGACCGACTCGAAAGCAAAG-30 and 50-TTAACGCACAAGCCC
AAGTC-30 , and cloned into pCS2þ (Addgene). The resulting vector pCS2:zVsx2
was then linearized with NotI and transcribed with mMESSAGE mMACHINE SP6
Kit (Ambion) to synthesize capped RNA. Vsx2 RNA was injected in one-cell-stage
embryos (200 pg and 340 pg per embryo), both in medaka and zebrafish. Similarly,
the vector pCS2:GFPVsx2, obtained after in-frame fusion of eGFP to the
50 sequence of vsx2 in pCS2:zVsx2, was employed to synthesize capped GFPVsx2
RNA.
ChIP detected by qPCR (ChIP–qPCR). The physical interaction between
H6_10137 and Vsx2 was tested by ChIP–qPCR using anti-GFP antibodies (Abcam)
in zebrafish embryos expressing the fusion protein GFPVsx2. In brief, wild-type
zebrafish embryos were injected at the one-cell stage, (300 pg per embryo) with
capped GFPVsx2 RNA. At 24 h.p.f., 300 heads were dissected and fixed in 1%
formaldehyde for 15min at room temperature. After crosslinking, the tissues were
washed, sonicated and immunoprecipitated overnight with prebound anti-GFP-
Dynabeads (Sigma). Precipitated DNA fragments and control input samples were
subjected to DNA extraction with phenol:chloroform:isoamyl alcohol 25:24:1 and
washed with 100% ethanol. RT–qPCRs were performed using the following
primers: 50-CAGTGAAGAAGGAAAGCATGG-30 and 50-TGCATCTTACAGA
AGAAGAGA-30 for H6_10137; 50-GTACCGATTTAATACTGTGG-30 and 50-CA
GTATAGCATACGCTTTTA-30 for vsx1 (positive control); and 50-CTCTCAAAT
CCGGAGATGCT-30 and 5´-GAAGCTCTCCACACACATGG-3´for Ef1a (negative
control).
Patterning
Mitf
Otx2
Vsx2
NRS
Apical Basal Apical Basal
Retina neuroblasts Retina neuroblasts
*
*
H6_10137
enhancer
Morphogenesis
Neural retina Optic stalk Retina pigmented epithelium Lens ectoderm Time Constriction*
Optic cup folding
opo
?
FGF
Cell proliferation and differentiation
Figure 8 | Proposed model for vsx2-coordinated coupling between neural retina patterning and morphogenesis (a) During optic vesicle stages,
vsx2 is required to establish neural retina identity, by suppressing RPE specifiers such as mitf. Our work shows that at this stage, vsx2 binds to the H6_10137
enhancer and regulates opo transcription levels. Potential regulatory activity of other neural retina specifiers (NRS) on the H6_10137 element has also
been depicted. (b,c) During optic cup folding, opo is required for basal constriction of the neuroblasts’ feet *28, while vsx2 maintains the proliferative state
and identity of the retinal domain.
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